Abstract Details

Title Tolerability with No Loss of Efficacy after Overnight Switch from Immediate Release (IR) Ropinirole to a New Extended-Release Formulation, Ropinirole CR, in Primary Restless Legs Syndrome (RLS)

Topic Sleep

Presentation(s) (-)

Poster/Presentation
Number 007

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Daniel Lee, MD, FAAN (University of Kentucky)	No disclosure on file
Mary Castiglia	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��